Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 225

1.

Fractionated stereotactic body radiotherapy for up to five prostate cancer oligometastases: Interim outcomes of a prospective clinical trial.

Bowden P, See AW, Frydenberg M, Haxhimolla H, Costello AJ, Moon D, Ruljancich P, Grummet J, Crosthwaite A, Pranavan G, Peters JS, So K, Gwini SM, McKenzie DP, Nolan S, Smyth LML, Everitt C.

Int J Cancer. 2020 Jan 1;146(1):161-168. doi: 10.1002/ijc.32509. Epub 2019 Jun 28.

PMID:
31199504
2.

Prostatic nerve subtypes independently predict biochemical recurrence in prostate cancer.

Reeves FA, Battye S, Roth H, Peters JS, Hovens C, Costello AJ, Corcoran NM.

J Clin Neurosci. 2019 May;63:213-219. doi: 10.1016/j.jocn.2019.01.052. Epub 2019 Feb 13.

PMID:
30772200
3.

Preparation of fluorescent in situ hybridisation probes without the need for optimisation of fragmentation.

McCoy PJ, Costello AJ, Corcoran NM, Hovens CM, Clarkson MJ.

MethodsX. 2018 Nov 27;6:22-34. doi: 10.1016/j.mex.2018.11.015. eCollection 2019.

4.

Late biochemical recurrence after radical prostatectomy is associated with a slower rate of progression.

Chow K, Herrera P, Stuchbery R, Peters JS, Costello AJ, Hovens CM, Corcoran NM.

BJU Int. 2019 Jun;123(6):976-984. doi: 10.1111/bju.14556. Epub 2018 Oct 19.

PMID:
30248237
5.

Robot-assisted abdominal wall excision of a PSMA-detected prostate cancer metastasis.

Moran D, Gross T, Gavin D, Costello AJ.

J Robot Surg. 2019 Jun;13(3):515-517. doi: 10.1007/s11701-018-0871-9. Epub 2018 Sep 5.

PMID:
30187209
6.

Ga-labeled Prostate-specific Membrane Antigen Ligand-positron-emission Tomography: Still Just the Tip of the Iceberg.

Dundee P, Gross T, Moran D, Ryan A, Ballok Z, Peters J, Costello AJ.

Urology. 2018 Oct;120:187-191. doi: 10.1016/j.urology.2018.06.029. Epub 2018 Jun 28.

7.

Obesity suppresses tumor attributable PSA, affecting risk categorization.

Chow K, Mangiola S, Vazirani J, Peters JS, Costello AJ, Hovens CM, Corcoran NM.

Endocr Relat Cancer. 2018 May;25(5):561-568. doi: 10.1530/ERC-17-0466.

PMID:
29661963
8.

Periprostatic fat tissue transcriptome reveals a signature diagnostic for high-risk prostate cancer.

Mangiola S, Stuchbery R, Macintyre G, Clarkson MJ, Peters JS, Costello AJ, Hovens CM, Corcoran NM.

Endocr Relat Cancer. 2018 May;25(5):569-581. doi: 10.1530/ERC-18-0058. Epub 2018 Mar 28.

PMID:
29592867
9.

Robotic-assisted radical cystectomy with intracorporeal urinary diversion versus open: early Australian experience.

Chow K, Zargar H, Corcoran NM, Costello AJ, Peters JS, Dundee P.

ANZ J Surg. 2018 Oct;88(10):1028-1032. doi: 10.1111/ans.14361. Epub 2018 Jan 8.

PMID:
29316106
10.

3D modelling of radical prostatectomy specimens: Developing a method to quantify tumor morphometry for prostate cancer risk prediction.

Hovens MC, Lo K, Kerger M, Pedersen J, Nottle T, Kurganovs N, Ryan A, Peters JS, Moon D, Costello AJ, Corcoran NM, Hong MKH.

Pathol Res Pract. 2017 Dec;213(12):1523-1529. doi: 10.1016/j.prp.2017.09.022. Epub 2017 Sep 27.

PMID:
29033190
11.

Changing face of robot-assisted radical prostatectomy in Melbourne over 12 years.

Sathianathen NJ, Lamb AD, Lawrentschuk NL, Goad JR, Peters J, Costello AJ, Murphy DG, Moon DA.

ANZ J Surg. 2018 Mar;88(3):E200-E203. doi: 10.1111/ans.14169. Epub 2017 Sep 18.

PMID:
28922689
12.

Fournier's gangrene in a man on empagliflozin for treatment of Type 2 diabetes.

Kumar S, Costello AJ, Colman PG.

Diabet Med. 2017 Nov;34(11):1646-1648. doi: 10.1111/dme.13508.

PMID:
28887847
13.

Editorial Comment.

Costello AJ.

J Urol. 2017 Sep;198(3):606. doi: 10.1016/j.juro.2017.03.146. Epub 2017 May 24. No abstract available.

PMID:
28551452
14.

Comparing nodal versus bony metastatic spread using tumour phylogenies.

Mangiola S, Hong MK, Cmero M, Kurganovs N, Ryan A, Costello AJ, Corcoran NM, Macintyre G, Hovens CM.

Sci Rep. 2016 Sep 22;6:33918. doi: 10.1038/srep33918.

15.

High-resolution Map of Somatic Periprostatic Nerves.

Reeves F, Battye S, Borin JF, Corcoran NM, Costello AJ.

Urology. 2016 Nov;97:160-165. doi: 10.1016/j.urology.2016.08.027. Epub 2016 Aug 26.

PMID:
27569453
16.

An online psychological intervention can improve the sexual satisfaction of men following treatment for localized prostate cancer: outcomes of a Randomised Controlled Trial evaluating My Road Ahead.

Wootten AC, Meyer D, Abbott JM, Chisholm K, Austin DW, Klein B, McCabe M, Murphy DG, Costello AJ.

Psychooncology. 2017 Jul;26(7):975-981. doi: 10.1002/pon.4244. Epub 2016 Sep 26.

PMID:
27503036
17.

Routinely reported 'equivocal' lymphovascular invasion in prostatectomy specimens is associated with adverse outcomes.

Galiabovitch E, Hovens CM, Peters JS, Costello AJ, Battye S, Norden S, Ryan A, Corcoran NM.

BJU Int. 2017 Apr;119(4):567-572. doi: 10.1111/bju.13594. Epub 2016 Aug 31.

18.

Reduction in expression of the benign AR transcriptome is a hallmark of localised prostate cancer progression.

Stuchbery R, Macintyre G, Cmero M, Harewood LM, Peters JS, Costello AJ, Hovens CM, Corcoran NM.

Oncotarget. 2016 May 24;7(21):31384-92. doi: 10.18632/oncotarget.8915.

19.

Validation of the novel International Society of Urological Pathology 2014 five-tier Gleason grade grouping: biochemical recurrence rates for 3+5 disease may be overestimated.

van den Bergh RC, van der Kwast TH, de Jong J, Zargar H, Ryan AJ, Costello AJ, Murphy DG, van der Poel HG.

BJU Int. 2016 Oct;118(4):502-5. doi: 10.1111/bju.13478. Epub 2016 Apr 1. No abstract available.

20.

Prognosis of node-positive bladder cancer in 2016.

VAN Bruwaene S, Costello AJ, VAN Poppel H.

Minerva Urol Nefrol. 2016 Apr;68(2):125-37. Epub 2016 Mar 3. Review.

21.

A urinary microRNA signature can predict the presence of bladder urothelial carcinoma in patients undergoing surveillance.

Sapre N, Macintyre G, Clarkson M, Naeem H, Cmero M, Kowalczyk A, Anderson PD, Costello AJ, Corcoran NM, Hovens CM.

Br J Cancer. 2016 Feb 16;114(4):454-62. doi: 10.1038/bjc.2015.472. Epub 2016 Jan 26.

22.

The impact of multidisciplinary team meetings on patient assessment, management and outcomes in oncology settings: A systematic review of the literature.

Pillay B, Wootten AC, Crowe H, Corcoran N, Tran B, Bowden P, Crowe J, Costello AJ.

Cancer Treat Rev. 2016 Jan;42:56-72. doi: 10.1016/j.ctrv.2015.11.007. Epub 2015 Nov 24. Review.

PMID:
26643552
23.

Stimulation of the Neurovascular Bundle Results in Rhabdosphincter Contraction in a Proportion of Men Undergoing Radical Prostatectomy.

Reeves F, Everaerts W, Murphy DG, Kiers L, Peters J, Costello T, Corcoran NM, Costello AJ.

Urology. 2016 Jan;87:133-9. doi: 10.1016/j.urology.2015.09.016. Epub 2015 Oct 9.

PMID:
26456743
24.

The urologist's role in multidisciplinary management of placenta percreta.

Norris BL, Everaerts W, Posma E, Murphy DG, Umstad MP, Costello AJ, Wrede CD, Kearsley J.

BJU Int. 2016 Jun;117(6):961-5. doi: 10.1111/bju.13332. Epub 2015 Oct 29.

25.

Is there a place for cytoreduction in metastatic prostate cancer?

Reeves F, Costello AJ.

BJU Int. 2016 Jul;118(1):14-5. doi: 10.1111/bju.13323. Epub 2015 Oct 10. No abstract available.

26.

Patterns-of-care and health economic analysis of robot-assisted radical prostatectomy in the Australian public health system.

Basto M, Sathianathen N, Te Marvelde L, Ryan S, Goad J, Lawrentschuk N, Costello AJ, Moon DA, Heriot AG, Butler J, Murphy DG.

BJU Int. 2016 Jun;117(6):930-9. doi: 10.1111/bju.13317. Epub 2015 Oct 1.

27.

Genotypic Characterization of Methicillin-Resistant Staphylococcus aureus Recovered at Baseline from Phase 3 Pneumonia Clinical Trials for Ceftobiprole.

Mendes RE, Deshpande LM, Costello AJ, Farrell DJ, Jones RN, Flamm RK.

Microb Drug Resist. 2016 Jan;22(1):53-8. doi: 10.1089/mdr.2014.0307. Epub 2015 Jul 31.

28.

Does perineural invasion in a radical prostatectomy specimen predict biochemical recurrence in men with prostate cancer?

Reeves F, Hovens CM, Harewood L, Battye S, Peters JS, Costello AJ, Corcoran NM.

Can Urol Assoc J. 2015 May-Jun;9(5-6):E252-5. doi: 10.5489/cuaj.2619.

29.

"We Used a Validated Questionnaire": What Does This Mean and Is It an Accurate Statement in Urologic Research?

Dowrick AS, Wootten AC, Murphy DG, Costello AJ.

Urology. 2015 Jun;85(6):1304-10. doi: 10.1016/j.urology.2015.01.046. Epub 2015 Apr 14.

PMID:
25881867
30.

Reply: To PMID 25881862.

Dowrick AS, Wootten AC, Murphy DG, Costello AJ.

Urology. 2015 Jun;85(6):1310-1. doi: 10.1016/j.urology.2015.01.049. Epub 2015 Apr 14. No abstract available.

PMID:
25881861
31.

Tracking the origins and drivers of subclonal metastatic expansion in prostate cancer.

Hong MK, Macintyre G, Wedge DC, Van Loo P, Patel K, Lunke S, Alexandrov LB, Sloggett C, Cmero M, Marass F, Tsui D, Mangiola S, Lonie A, Naeem H, Sapre N, Phal PM, Kurganovs N, Chin X, Kerger M, Warren AY, Neal D, Gnanapragasam V, Rosenfeld N, Pedersen JS, Ryan A, Haviv I, Costello AJ, Corcoran NM, Hovens CM.

Nat Commun. 2015 Apr 1;6:6605. doi: 10.1038/ncomms7605.

32.

Identification of candidates for observation.

van den Bergh RC, Murphy DG, Costello AJ.

Curr Opin Urol. 2015 May;25(3):252-7. doi: 10.1097/MOU.0000000000000159. Review.

PMID:
25692721
33.

Evaluation of models predicting insignificant prostate cancer to select men for active surveillance of prostate cancer.

Wong LM, Neal DE, Finelli A, Davis S, Bonner C, Kapoor J, Trachtenberg J, Thomas B, Hovens CM, Costello AJ, Corcoran NM.

Prostate Cancer Prostatic Dis. 2015 Jun;18(2):137-43. doi: 10.1038/pcan.2015.1. Epub 2015 Feb 10.

PMID:
25667108
34.

Preservation of the neurovascular bundles is associated with improved time to continence after radical prostatectomy but not long-term continence rates: results of a systematic review and meta-analysis.

Reeves F, Preece P, Kapoor J, Everaerts W, Murphy DG, Corcoran NM, Costello AJ.

Eur Urol. 2015 Oct;68(4):692-704. doi: 10.1016/j.eururo.2014.10.020. Epub 2014 Oct 29. Review.

PMID:
25454614
35.

Preliminary results of a randomised controlled trial of an online psychological intervention to reduce distress in men treated for localised prostate cancer.

Wootten AC, Abbott JA, Meyer D, Chisholm K, Austin DW, Klein B, McCabe M, Murphy DG, Costello AJ.

Eur Urol. 2015 Sep;68(3):471-9. doi: 10.1016/j.eururo.2014.10.024. Epub 2014 Oct 28.

PMID:
25454611
36.

Pushing the robot-assisted prostatectomy envelope--to the safety limits? Better outcomes.

Costello AJ.

BJU Int. 2014 Aug;114(2):161. doi: 10.1111/bju.12805. No abstract available.

37.

Streamlining the assessment of haematuria: 3-year outcomes of a dedicated haematuria clinic.

Sapre N, Hayes E, Bugeja P, Corcoran NM, Costello AJ, Anderson PD.

ANZ J Surg. 2015 May;85(5):334-8. doi: 10.1111/ans.12742. Epub 2014 Jul 2.

PMID:
24989960
38.

Serotype distribution and antimicrobial susceptibility of USA Streptococcus pneumoniae isolates collected prior to and post introduction of 13-valent pneumococcal conjugate vaccine.

Mendes RE, Costello AJ, Jacobs MR, Biek D, Critchley IA, Jones RN.

Diagn Microbiol Infect Dis. 2014 Sep;80(1):19-25. doi: 10.1016/j.diagmicrobio.2014.05.020. Epub 2014 May 24.

PMID:
24974272
39.

Pedicled dartos flap interposition in rectourethral fistula repair.

Huang JG, Costello AJ, Agarwal DK.

ANZ J Surg. 2014 Jun;84(6):495. doi: 10.1111/ans.12500. No abstract available.

PMID:
24894038
40.

Bladder cancer biorepositories in the "-omics" era: integrating quality tissue specimens with comprehensive clinical annotation.

Sapre N, Hong MK, Huang JG, Pedersen J, Ryan A, Anderson P, Costello AJ, Corcoran NM, Hovens CM.

Biopreserv Biobank. 2013 Jun;11(3):166-72. doi: 10.1089/bio.2012.0062. Epub 2013 May 31.

PMID:
24850094
41.

Web-based trial to evaluate the efficacy and safety of tolterodine ER 4 mg in participants with overactive bladder: REMOTE trial.

Orri M, Lipset CH, Jacobs BP, Costello AJ, Cummings SR.

Contemp Clin Trials. 2014 Jul;38(2):190-7. doi: 10.1016/j.cct.2014.04.009. Epub 2014 May 2.

PMID:
24792229
42.

Canonical androstenedione reduction is the predominant source of signaling androgens in hormone-refractory prostate cancer.

Fankhauser M, Tan Y, Macintyre G, Haviv I, Hong MK, Nguyen A, Pedersen JS, Costello AJ, Hovens CM, Corcoran NM.

Clin Cancer Res. 2014 Nov 1;20(21):5547-57. doi: 10.1158/1078-0432.CCR-13-3483. Epub 2014 Apr 25.

43.

The impact of prostate cancer on partners: a qualitative exploration.

Wootten AC, Abbott JM, Osborne D, Austin DW, Klein B, Costello AJ, Murphy DG.

Psychooncology. 2014 Nov;23(11):1252-8. doi: 10.1002/pon.3552. Epub 2014 Apr 25.

PMID:
24764291
44.

Prostate cancer surgery vs radiation: has the fat lady sung?

Costello AJ.

BJU Int. 2014 Feb;113(2):179-80. doi: 10.1111/bju.12393. No abstract available.

45.

Curated microRNAs in urine and blood fail to validate as predictive biomarkers for high-risk prostate cancer.

Sapre N, Hong MK, Macintyre G, Lewis H, Kowalczyk A, Costello AJ, Corcoran NM, Hovens CM.

PLoS One. 2014 Apr 4;9(4):e91729. doi: 10.1371/journal.pone.0091729. eCollection 2014.

46.

My Road Ahead study protocol: a randomised controlled trial of an online psychological intervention for men following treatment for localised prostate cancer.

Wootten AC, Abbott JA, Chisholm KE, Austin DW, Klein B, McCabe MP, Meyer D, Costello AJ, Murphy DG.

BMC Cancer. 2014 Feb 11;14:83. doi: 10.1186/1471-2407-14-83.

47.

The Melbourne Consensus Statement on the early detection of prostate cancer.

Murphy DG, Ahlering T, Catalona WJ, Crowe H, Crowe J, Clarke N, Cooperberg M, Gillatt D, Gleave M, Loeb S, Roobol M, Sartor O, Pickles T, Wootten A, Walsh PC, Costello AJ.

BJU Int. 2014 Feb;113(2):186-8. doi: 10.1111/bju.12556. Review.

48.

The dilemmas of prostate cancer screening.

Lawrentschuk N, Murphy DG, Costello AJ.

Med J Aust. 2013 Nov 4;199(9):583. No abstract available.

PMID:
24182216
49.

Gene-based urinary biomarkers for bladder cancer: an unfulfilled promise?

Sapre N, Anderson PD, Costello AJ, Hovens CM, Corcoran NM.

Urol Oncol. 2014 Jan;32(1):48.e9-17. doi: 10.1016/j.urolonc.2013.07.002. Epub 2013 Oct 17. Review.

PMID:
24140246
50.

Positive surgical margins: rate, contributing factors and impact on further treatment: findings from the Prostate Cancer Registry.

Evans SM, Millar JL, Frydenberg M, Murphy DG, Davis ID, Spelman T, Bolton DM, Giles GG, Dean J, Costello AJ, Frauman AG, Kearns PA, Day L, Daniels C, McNeill JJ.

BJU Int. 2014 Nov;114(5):680-90. doi: 10.1111/bju.12509. Epub 2014 Feb 14.

Supplemental Content

Loading ...
Support Center